ReviewDiagnosis and Management of Behavioral Variant Frontotemporal Dementia
Section snippets
Epidemiology
The incidence of FTD seems to peak during the 6th and 7th decades of life, at 2.2, 3.3, and 8.9/100,000 person-years at 40–49, 50–59, and 60–69, respectively. Mean age at onset varies somewhat across FTD subtypes, with bvFTD having the earliest onset, followed by svPPA and then nvfPPA (18). The average survival time from diagnosis to death ranges from 3 years for bvFTD patients with motor neuron disease to approximately 12 years in patients with semantic variant PPA (19). The mean age at
Clinical Presentations
In 2011 an international consortium developed revised criteria for the diagnosis of bvFTD (24) (Table S2 in Supplement 1). The new criteria were designed to increase diagnostic sensitivity compared with previous criteria by Neary et al. (25). In a comparison of the new criteria with histological evidence of FTLD, the sensitivity was 85% and specificity was 95% for probable bvFTD (26).
People with bvFTD frequently have limited insight into their illness, making an informant critically important
Clinicopathological Correlation: Histopathology and Genetics
Behavioral variant FTD involves atrophy of the orbitofrontal, anterior cingulate, anterior insular, and anterior temporal cortices, particularly within the right hemisphere (37). Functional studies have increasingly demonstrated network connectivity disruption in addition to modular and structural atrophy. Different degenerative diseases have been associated with unique networks that might explain particular symptoms. For example, AD has been tied to changes in the default mode network,
Tau
Tau is important in the pathogenesis of a variety of neurodegenerative conditions, including AD and FTD. Tau protein normally helps to maintain microtubular structure. There are six isoforms of tau, three of which have three microtubule binding repeats, and three of which have four repeats. Approximately half of all patients with bvFTD have tau aggregates: three microtubule binding repeats tau in Pick’s disease, and four microtubule binding repeats tau in PSP and CBD (Figures S1–S3 in
Trans-Activator Regulatory DNA Binding Protein 43
The TDP-43 protein is found in approximately half of bvFTD cases on histological examination and is seen in all cases of FTD-ALS. There are three major patterns of TDP-43 pathology: Type A, Type B, and Type C, which correlate with different forms of FTD. The FTLD TDP-43 type A is characterized by inclusions that occur with progranulin mutations but can be seen in other patients with bvFTD or nfvPPA in whom progranulin mutations are absent. Type B is typical for FTD with motor neuron disease,
Differential Diagnosis
A careful history, combined with laboratory studies and neuroimaging, can usually exclude reversible mimics of FTD such as neurological infections, metabolic disorders, vascular disease, and paraneoplastic conditions.
Patients with bvFTD might exhibit symptoms suggestive of obsessive-compulsive disorder, bipolar disorder, depression, or schizophrenia. An onset of symptoms in patients in middle age should lead to consideration of the inclusion of bvFTD in the differential diagnosis (17). Other
Diagnosis of Frontotemporal Dementia
A diagnosis of FTD is made primarily by clinical assessment. Despite potential diagnostic pitfalls, the presence of abnormal social conduct, change of eating habits, stereotyped behaviors, and apathy in the relative absence of memory or visuospatial deficit will usually lead to the correct diagnosis (24).
A short neuropsychological battery to compare different cognitive domains can be an efficient way of aiding the differential diagnosis. Neuropsychological evaluation should show primarily
Treatment
The proper treatment of FTD requires an individually tailored approach. Because no treatment is yet available that changes the course of the neurodegenerative disease, the focus of medical therapy is on symptomatic relief (76). The difficult behaviors typical for bvFTD can place a great deal of stress on caregivers. Education and counseling about the neurological basis of the disease can offer some relief to frustrated friends and family. Resources such as The Association for Frontotemporal
Conclusions
Frontotemporal dementia is increasingly recognized as not only a common cause of early-onset dementia but also a cause of manic, depressive, obsessive-compulsive, or psychotic symptoms. The syndrome of bvFTD can result from a number of different proteinopathies, and some cases have a genetic etiology. Recognizing the core features of bvFTD as well as the variety of possible presentations can avoid misdiagnosis. This will permit the appropriate selection of symptomatic therapies and might
References (100)
- et al.
Prevalence of dementia subtypes: A 30-year retrospective survey of neuropathological reports
Arch Gerontol Geriatriatr
(2009) - et al.
Neuroanatomical correlates of impaired recognition of emotion in dementia
Neuropsychologia
(2006) Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis
Arch Gerontol Geriatr
(1987)Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology
Arch Gerontol Geriatr
(1987)- et al.
Neurodegenerative diseases target large-scale human brain networks
Neuron
(2009) - et al.
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: An international initiative
Lancet Neurol
(2007) - et al.
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS
Neuron
(2011) - et al.
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD
Neuron
(2011) - et al.
Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS
Neuron
(2013) - et al.
Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: Rational therapeutic approach to frontotemporal dementia
J Biol Chem
(2011)
Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls
Neuron
Behavioural-variant frontotemporal dementia: Diagnosis, clinical staging, and management
Lancet Neurol
The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia
Neurochem Int
Preliminary findings: Behavioral worsening on donepezil in patients with frontotemporal dementia
Am J Geriatr Psychiatry
Memantine in patients with frontotemporal lobar degeneration: A multicentre, randomised, double-blind, placebo-controlled trial
Lancet Neurol
Uber die beziehungen der senilen hirnatropie zur aphasie
Pragen Medizinischen Wochenschrift
Frontotemporal dementia: Its rediscovery
Eur Neurol
The prevalence of frontotemporal dementia
Neurology
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration
Acta Neuropathologica
Frontotemporal degeneration, Pick’s disease, Pick complex, and Ravel
Ann Neurol
Frontotemporal lobar degeneration: Epidemiology, pathophysiology, diagnosis and management
CNS Drugs
Classification of primary progressive aphasia and its variants
Neurology
Midcingulate involvement in progressive supranuclear palsy and tau positive frontotemporal dementia
J Neurol Neurosurg Psychiatry
Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick’s disease, corticobasal degeneration and progressive supranuclear palsy
Acta Neuropathologica
Clinicopathological correlations in corticobasal degeneration
Ann Neurol
Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: Phenotypic comparison to bvFTD with Pick’s disease
J Mol Neurosci
Clinical phenomenology and neuroimaging correlates in ALS-FTD
J Mol Neurosci
A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP)
Neuropath Appl Neurobiol
Clinical characterization of bvFTD due to FUS neuropathology
Neurocase
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration
Brain
The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: Rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease
J Clin Psychiatry
Frontotemporal lobar degeneration: Demographic characteristics of 353 patients
Arch Neurol
Frontotemporal dementia progresses to death faster than Alzheimer disease
Neurology
Frontotemporal dementia in The Netherlands: Patient characteristics and prevalence estimates from a population-based study
Brain
The epidemiology of frontotemporal dementia
Int Rev Psychiatry
Presenile dementia syndromes: An update on taxonomy and diagnosis
J Neurol Neurosurg Psychiatry
Frequency of dementia etiologies in four ethnic groups
Dement Geriatr Cogn Disord
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Brain
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neurology
Sensitivity and specificity of FTDC criteria for behavioral variant frontotemporal dementia
Neurology
Loss of insight and functional neuroimaging in frontotemporal dementia
J Neuropsychiatry Clin Neurosci
Structural anatomy of empathy in neurodegenerative disease
Brain
Neuroanatomical correlates of behavioural disorders in dementia
Brain
Voxel-based morphometry in patients with obsessive-compulsive behaviors in behavioral variant frontotemporal dementia
Eur J Neurol
Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia
Neurology
Apathy in frontotemporal dementia: Behavioral and neuroimaging correlates
Behav Neurol
Clinicopathological correlates in frontotemporal dementia
Ann Neurol
Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia
Arch Neurol
Intrinsic connectivity network disruption in progressive supranuclear palsy
Ann Neurol
Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: Evidence from functional MRI
Proc Natl Acad Sci U S A
Cited by (75)
Assessing natural metalinguistic skills in people with Alzheimer's disease and frontotemporal dementia
2021, Journal of Communication DisordersLongitudinal transcriptomic analysis of altered pathways in a CHMP2B<sup>intron5</sup>-based model of ALS-FTD
2020, Neurobiology of DiseaseWhen you hear hoofbeats, think horses and zebras: The importance of a wide differential when it comes to frontotemporal lobar degeneration
2020, Asian Journal of PsychiatryCitation Excerpt :Many of the initial symptoms of behavioral variant FTD patients can be mistaken for symptoms of psychiatric disorders making the diagnosis more complicated. In FTD, these symptoms correlate with atrophy in the frontal and temporal regions of cortex (Pressman and Miller, 2014). In our second case, patient exhibited indifference towards his diagnosis, complications and how this is impacting his family or other care providers.
Frontotemporal dementia
2019, Handbook of Clinical NeurologyCitation Excerpt :Several other drugs, like lithium and some anticonvulsants, have been tested in FTD with negative or inconclusive results. Risks of toxicity are generally deemed to outweigh theoretical benefits (Pressman and Miller, 2014). FTD is increasingly recognized as a leading cause of early-onset dementia.
Correlates of Functional Impairment in Patients with the Behavioral Variant of Frontotemporal Dementia: A PRISMA-Compliant Systematic Review
2023, International Journal of Molecular Sciences